|
瑞马唑仑在麻醉学科的应用进展
|
Abstract:
根据“软药”策略而研发的新型超短效水溶性苯二氮卓类镇静药——瑞马唑仑(Remimazolam),具有起效快、消除快、长时间用无蓄积、基本无注射痛、顺行性遗忘、对肝肾功能依赖小、羧酸代谢物唑仑丙酸(CNS 7054)无药理作用、对呼吸系统和循环系统的影响甚微、有特异拮抗剂——氟马西尼等特点,在麻醉学科应用前景良好,并有望成为静脉镇静药的新选择。本文就瑞马唑仑的研发史、药理特点、麻醉学科应用及使用注意事项等做阐述,旨在为瑞马唑仑在麻醉学科的应用提供参考。
Remimazolam, a new type of ultra-short-acting water-soluble benzodiazepine sedative developed according to the strategy of “soft medicine”, has the characteristics of quick onset, rapid elimination, no accumulation after long-term use, basically no injection pain, anterograde amnesia, little dependence on liver and kidney functions, no pharmacological effect of the carboxylic acid metabolite zolampropionic acid (CNS 7054), little influence on the respiratory system and circulatory system, and a specific antagonist-flumazenil and has a good application prospect in anesthesiology. It is expected to be a new option for intravenous sedatives. This article expounds the research and development history, pharmacological characteristics, application and precautions of remimazolam in anesthesiology, aiming at providing reference for the anesthesiology application of Rimazzolam.
[1] | National Bureau of Statistics of China (2020) Number of Surgeries in Chinese Healthcare Institutions 2018. http://www.stats.gov.cn/english/ |
[2] | 肖颜, 陶广华. 择期手术患者术前焦虑状态及其影响因素分析[J]. 护理实践与研究, 2023, 20(1): 37-40. |
[3] | 薛庆生, 罗艳, 于布为. 现代麻醉学的发展与展望[J]. 健康管理, 2014(5): 16-18. |
[4] | Absalom, A.R., Glen, J.I., Zwart, G.J., et al. (2016) Target-Controlled Infusion: A Mature Technology. Anesthesia and Analgesia, 122, 70-78. https://doi.org/10.1213/ANE.0000000000001009 |
[5] | Egan, T.D. (2009) Is Anesthesiology Going Soft? Trends in Fragile Pharmacology. Anesthesiology, 111, 229-230. https://doi.org/10.1097/ALN.0b013e3181ae8460 |
[6] | Chen, S.-H., Yuan, T.-M., Zhang, J., et al. (2021) Remimazolam Tosilate in Upper Gastrointestinal Endoscopy: A Multicenter, Randomized, Non-Inferiority, Phase III Trial. Journal of Gastroenterology and Hepatology, 36, 474-481. https://doi.org/10.1111/jgh.15188 |
[7] | Kilpatrick, G.J. (2021) Remimazolam: Non-Clinical and Clinical Profile of a New Sedative/Anesthetic Agent. Frontiers in Pharmacology, 12, Article ID: 690875. https://doi.org/10.3389/fphar.2021.690875 |
[8] | (2021) Remimazolam Besylate. American Journal of Health-System Pharmacy: AJHP: Official Journal of the American Society of Health-System Pharmacists, 78, 935-938. https://doi.org/10.1093/ajhp/zxab091 |
[9] | 刘颜. 瑞马唑仑衍生物的设计合成及其生物活性研究[D]: [博士学位论文]. 重庆: 重庆医科大学, 2016. |
[10] | Wang, M., Zhao, X., Yin, P.F., et al. (2022) Profile of Remimazolam in Anesthesiology: A Narrative Review of Clinical Research Progress. Drug Design, Development and Therapy, 16, 3431-3444. https://doi.org/10.2147/DDDT.S375957 |
[11] | Brogden, R. and Goa, K. (1991) Flumazenil. A Reappraisal of Its Pharmacological Properties and Therapeutic Efficacy as a Benzodiazepine Antagonist. Drugs, 42, 1061-1089. https://doi.org/10.2165/00003495-199142060-00010 |
[12] | Stamenkovic, D.M., Rancic, N.K., Latas, M.B., et al. (2018) Preoperative Anxiety and Implications on Postoperative Recovery: What Can We Do to Change Our History. Minerva Anestesiologica, 84, 1307-1317. https://doi.org/10.23736/S0375-9393.18.12520-X |
[13] | Kassai, B., Rabilloud, M., Dantony, E., et al. (2016) Introduction of a Paediatric Anaesthesia Comic Information Leaflet Reduced Preoperative Anxiety in Children. British Journal of Anaesthesia, 117, 95-102. https://doi.org/10.1093/bja/aew154 |
[14] | Pesic, M., Schippers, F., Saunders, R., et al. (2020) Pharmacokinetics and Pharmacodynamics of Intranasal Remimazolam—A Randomized Controlled Clinical Trial. European Journal of Clinical Pharmacology, 76, 1505-1516. https://doi.org/10.1007/s00228-020-02984-z |
[15] | Kim, S.-H. and Fechner, J. (2022) Remimazolam—Current Knowledge on a New Intravenous Benzodiazepine Anesthetic Agent. Korean Journal of Anesthesiology, 75, 307-315. https://doi.org/10.4097/kja.22297 |
[16] | Borkett, K.M., Riff, D.S., Schwartz, H.I., et al. (2015) A Phase IIa, Randomized, Double-Blind Study of Remimazolam (CNS 7056) versus Midazolam for Sedation in Upper Gastrointestinal Endoscopy. Anesthesia and Analgesia, 120, 771-780. https://doi.org/10.1213/ANE.0000000000000548 |
[17] | Rex, D.K., Bhandari, R., Desta, T., et al. (2018) A Phase III Study Evaluating the Efficacy and Safety of Remimazolam (CNS 7056) Compared with Placebo and Midazolam in Patients Undergoing Colonoscopy. Gastrointestinal Endoscopy, 88, 427-437.E6. https://doi.org/10.1016/j.gie.2018.04.2351 |
[18] | Rex, D.K., Bhandari, R., Lorch, D.G., et al. (2021) Safety and Efficacy of Remimazolam in High Risk Colonoscopy: A Randomized Trial. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 53, 94-101. https://doi.org/10.1016/j.dld.2020.10.039 |
[19] | Yi, X.N., Xu, W.W. and Li, A.Z. (2022) The Clinical Application of Remimazolam Benzenesulfonate Combined with Esketamine Intravenous Anesthesia in Endoscopic Retrograde Cholangiopancreatography. BioMed Research International, 2022, Article ID: 5628687. https://doi.org/10.1155/2022/5628687 |
[20] | Pastis, N.J., Yarmus, L.B., Schippers, F., et al. (2019) Safety and Efficacy of Remimazolam Compared with Placebo and Midazolam for Moderate Sedation during Bronchoscopy. Chest, 155, 137-146. https://doi.org/10.1016/j.chest.2018.09.015 |
[21] | Yue, L.L., Ma, X.L., Li, N., et al. (2023) Remimazolam versus Propofol in Combination with Esketamine for Surgical Abortion: A Double-Blind Randomized Controlled Trial. Clinical and Translational Science, 16, 1606-1616. https://doi.org/10.1111/cts.13572 |
[22] | Fan, S.Y., Zhu, Y., Sui, C.Z., et al. (2023) Remimazolam Compared to Propofol during Hysteroscopy: A Safety and Efficacy Analysis. Pain and Therapy, 12, 695-706. https://doi.org/10.1007/s40122-023-00483-4 |
[23] | Wang, L.N., Wang, Y., Ma, L., et al. (2023) Cardiopulmonary Adverse Events of Remimazolam versus Propofol during Cervical Conization: A Randomized Controlled Trial. Drug Design, Development and Therapy, 17, 1233-1243. https://doi.org/10.2147/DDDT.S405057 |
[24] | Li, X., Tian, M.J., Deng, Y.L., et al. (2023) Advantages of Sedation with Remimazolam Compared to Midazolam for the Removal of Impacted Tooth in Patients with Dental Anxiety. Journal of Oral and Maxillofacial Surgery, 81, 536-545. https://doi.org/10.1016/j.joms.2023.02.001 |
[25] | Oue, K., Oda, A., Shimizu, Y., et al. (2023) Efficacy and Safety of Remimazolam Besilate for Sedation in Outpatients Undergoing Impacted Third Molar Extraction: A Prospective Exploratory Study. BMC Oral Health, 23, Article No. 774. https://doi.org/10.1186/s12903-023-03538-2 |
[26] | Hirano, T., Kimoto, Y., Kuratani, N., et al. (2023) Remimazolam for Pediatric Procedural Sedation: Results of an Institutional Pilot Program. Journal of Clinical Medicine, 12, Article No. 5937. https://doi.org/10.3390/jcm12185937 |
[27] | Ghaferi, A.A., Birkmeyer, J.D. and Dimick, J.B. (2009) Complications, Failure to Rescue, and Mortality with Major Inpatient Surgery in Medicare Patients. Annals of Surgery, 250, 1029-1034. https://doi.org/10.1097/SLA.0b013e3181bef697 |
[28] | Doi, M., Morita, K., Takeda, J., et al. (2020) Efficacy and Safety of Remimazolam versus Propofol for General Anesthesia: A Multicenter, Single-Blind, Randomized, Parallel-Group, Phase IIb/III Trial. Journal of Anesthesia, 34, 543-553. https://doi.org/10.1007/s00540-020-02788-6 |
[29] | Doi, M., Hirata, N., Suzuki, T., et al. (2020) Safety and Efficacy of Remimazolam in Induction and Maintenance of General Anesthesia in High-Risk Surgical Patients (ASA Class III): Results of a Multicenter, Randomized, Double-Blind, Parallel-Group Comparative Trial. Journal of Anesthesia, 34, 491-501. https://doi.org/10.1007/s00540-020-02776-w |
[30] | Xiao, Y.M., Wei, R., Chen, L.R., et al. (2022) Efficacy and Safety of Remimazolam for Procedural Sedation during Ultrasound-Guided Transversus Abdominis Plane Block and Rectus Sheath Block in Patients Undergoing Abdominal Tumor Surgery: A Single-Center Randomized Controlled Trial. BMC Anesthesiology, 22, Article No. 381. https://doi.org/10.1186/s12871-022-01927-8 |
[31] | Song, Y. and Zou, X.J. (2023) Remimazolam Dosing for Intraoperative Sedation in Elderly Patients Undergoing Hip Replacement with Combined Spinal-Epidural Anesthesia. European Review for Medical and Pharmacological Sciences, 27, 7485-7491. |
[32] | Tang, Y., Yang, X.B., Yu, Y., et al. (2022) Remimazolam Besylate versus Propofol for Long-Term Sedation during Invasive Mechanical Ventilation: A Pilot Study. Critical Care, 26, Article No. 279. https://doi.org/10.1186/s13054-022-04168-w |
[33] | Chen, X.Y., Zhang, J.C., Yuan, S.Y., et al. (2022) Remimazolam Besylate for the Sedation of Postoperative Patients Undergoing Invasive Mechanical Ventilation in the ICU: A Prospective Dose-Response Study. Scientific Reports, 12, Article No. 19022. https://doi.org/10.1038/s41598-022-20946-6 |
[34] | Yang, X.B., Tang, Y., Du, R.F., et al. (2023) Long-Term Sedation with Remimazolam Besylate versus Propofol in Critically Ill Patients during Invasive Mechanical Ventilation: A Study Protocol for a Multicenter Randomized Non-Inferior Trial. Frontiers in Pharmacology, 14, Article ID: 1139872. https://doi.org/10.3389/fphar.2023.1139872 |
[35] | Masui, K. (2020) Remimazolam Besilate, a Benzodiazepine, Has Been Approved for General Anesthesia! Journal of Anesthesia, 34, 479-482. https://doi.org/10.1007/s00540-020-02755-1 |
[36] | St?hr, T., Colin, P.J., Ossig, J., et al. (2021) Pharmacokinetic Properties of Remimazolam in Subjects with Hepatic or Renal Impairment. British Journal of Anaesthesia, 127, 415-423. https://doi.org/10.1016/j.bja.2021.05.027 |
[37] | Schüttler, J., Eisenried, A., Lerch, M., et al. (2020) Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part I. Pharmacokinetics and Clinical Pharmacodynamics. Anesthesiology, 132, 636-651. https://doi.org/10.1097/ALN.0000000000003103 |
[38] | Yamamoto, T., Kurabe, M. and Kamiya, Y. (2021) Re-Sleeping after Reversal of Remimazolam by Flumazenil. Journal of Anesthesia, 35, Article No. 322. https://doi.org/10.1007/s00540-021-02915-x |
[39] | Kim, K.M., Lee, H., Bang, J.-Y., et al. (2022) Anaphylaxis Following Remimazolam Administration during Induction of Anaesthesia. British Journal of Anaesthesia, 129, E122-E124. https://doi.org/10.1016/j.bja.2022.07.047 |
[40] | Sasaki, H., Hoshijima, H. and Mizuta, K. (2021) Ringer’s Acetate Solution-Induced Precipitation of Remimazolam. British Journal of Anaesthesia, 126, E87-E89. https://doi.org/10.1016/j.bja.2020.11.021 |